.png)
Cannabis Pharmaceuticals Market by Brand Type - Global Industry Analysis & Forecast to 2027
Published On : August 2020 Pages : 150 Category: Pharma & Healthcare Report Code : HC0812356
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Cannabis Pharmaceuticals Market by Brand Type (Sativex, Epidiolex) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Cannabis Pharmaceuticals Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Cannabis Pharmaceuticals are rigorously tested during production and governmental restrictions, for clinical research to define the safety and efficacy of using cannabis to treat diseases.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- GW Pharmaceuticals
- AbbVie Inc.
- Valeant Pharmaceuticals
- Insys Therapeutics, Inc.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Cannabis Pharmaceuticals Market, By Brand Type, Estimates and Forecast, 2017-2027 ($Million)
o Sativex
o Epidiolex
· Cannabis Pharmaceuticals Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o GW Pharmaceuticals
o AbbVie Inc.
o Valeant Pharmaceuticals
o Insys Therapeutics, Inc.
· Cannabis Pharmaceuticals Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Cannabis Pharmaceuticals Market , By Country
o U.S. Cannabis Pharmaceuticals Market
o Canada Cannabis Pharmaceuticals Market
o Mexico Cannabis Pharmaceuticals Market
o Europe
§ Europe Cannabis Pharmaceuticals Market , By Country
o Germany Cannabis Pharmaceuticals Market
o UK Cannabis Pharmaceuticals Market
o France Cannabis Pharmaceuticals Market
o Russia Cannabis Pharmaceuticals Market
o Italy Cannabis Pharmaceuticals Market
o Rest of Europe Cannabis Pharmaceuticals Market
o Asia-Pacific
§ Asia-Pacific Cannabis Pharmaceuticals Market , By Country
o China Cannabis Pharmaceuticals Market
o Japan Cannabis Pharmaceuticals Market
o South Korea Cannabis Pharmaceuticals Market
o India Cannabis Pharmaceuticals Market
o Southeast Asia Cannabis Pharmaceuticals Market
o Rest of Asia-Pacific Cannabis Pharmaceuticals Market
o South America
§ South America Cannabis Pharmaceuticals Market , By Country
o Brazil Cannabis Pharmaceuticals Market
o Argentina Cannabis Pharmaceuticals Market
o Columbia Cannabis Pharmaceuticals Market
o Rest of South America Cannabis Pharmaceuticals Market
o Middle East and Africa
§ Middle East and Africa Cannabis Pharmaceuticals Market , By Country
o Saudi Arabia Cannabis Pharmaceuticals Market
o UAE Cannabis Pharmaceuticals Market
o Egypt Cannabis Pharmaceuticals Market
o Nigeria Cannabis Pharmaceuticals Market
o South Africa Cannabis Pharmaceuticals Market
o Rest of MEA Cannabis Pharmaceuticals Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Cannabis Pharmaceuticals Market, By Brand Type
5.1. Introduction
5.2. Global Cannabis Pharmaceuticals Revenue and Market Share by Brand Type (2017-2021)
5.2.1. Global Cannabis Pharmaceuticals Revenue and Revenue Share by Brand Type (2017-2021)
5.3. Sativex
5.3.1. Global Sativex Revenue and Growth Rate (2017-2021)
5.4. Epidiolex
5.4.1. Global Epidiolex Revenue and Growth Rate (2017-2021)
6. Cannabis Pharmaceuticals Market, By Region
6.1. Introduction
6.2. Global Cannabis Pharmaceuticals Revenue and Market Share by Regions
6.2.1. Global Cannabis Pharmaceuticals Revenue by Regions (2017-2021)
6.3. North America Cannabis Pharmaceuticals by Countries
6.3.1. North America Cannabis Pharmaceuticals Revenue and Growth Rate (2017-2021)
6.3.2. North America Cannabis Pharmaceuticals Revenue (Million USD) by Countries (2017-2021)
6.3.3. United States
6.3.3.1. United States Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2021)
6.3.4. Canada
6.3.4.1. Canada Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2021)
6.3.5. Mexico
6.3.5.1. Mexico Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2021)
6.4. Europe Cannabis Pharmaceuticals by Countries
6.4.1. Europe Cannabis Pharmaceuticals Revenue and Growth Rate (2017-2021)
6.4.2. Europe Cannabis Pharmaceuticals Revenue (Million USD) by Countries (2017-2021)
6.4.3. Germany
6.4.3.1. Germany Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2021)
6.4.4. France
6.4.4.1. France Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2021)
6.4.5. UK
6.4.5.1. UK Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2021)
6.4.6. Russia
6.4.6.1. Russia Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2021)
6.4.7. Italy
6.4.7.1. Italy Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2021)
6.4.8. Rest of Europe
6.4.8.1. Rest of Europe Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2021)
6.5. Asia-Pacific Cannabis Pharmaceuticals by Countries
6.5.1. Asia-Pacific Cannabis Pharmaceuticals Revenue and Growth Rate (2017-2021)
6.5.2. Asia-Pacific Cannabis Pharmaceuticals Revenue (Million USD) by Countries (2017-2021)
6.5.3. China
6.5.3.1. China Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2021)
6.5.4. Japan
6.5.4.1. Japan Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2021)
6.5.5. Korea
6.5.5.1. Korea Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2021)
6.5.6. India
6.5.6.1. India Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2021)
6.5.7. Southeast Asia
6.5.7.1. Southeast Asia Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2021)
6.5.8. Rest of Asia-Pacific
6.5.8.1. Rest of Asia-Pacific Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2021)
6.6. South America Cannabis Pharmaceuticals by Countries
6.6.1. South America Cannabis Pharmaceuticals Revenue and Growth Rate (2017-2021)
6.6.2. South America Cannabis Pharmaceuticals Revenue (Million USD) by Countries (2017-2021)
6.6.3. Brazil
6.6.3.1. Brazil Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2021)
6.6.4. Argentina
6.6.4.1. Argentina Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2021)
6.6.5. Columbia
6.6.5.1. Columbia Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2021)
6.6.6. Rest of South America
6.6.6.1. Rest of South America Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2021)
6.7. Middle East and Africa Cannabis Pharmaceuticals by Countries
6.7.1. Middle East and Africa Cannabis Pharmaceuticals Revenue and Growth Rate (2017-2021)
6.7.2. Middle East and Africa Cannabis Pharmaceuticals Revenue (Million USD) by Countries (2017-2021)
6.7.3. Saudi Arabia
6.7.3.1. Saudi Arabia Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2021)
6.7.4. United Arab Emirates
6.7.4.1. United Arab Emirates Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2021)
6.7.5. Egypt
6.7.5.1. Egypt Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2021)
6.7.6. Nigeria
6.7.6.1. Nigeria Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2021)
6.7.7. South Africa
6.7.7.1. South Africa Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2021)
6.7.8. Turkey
6.7.8.1. Turkey Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2021)
6.7.9. Rest of Middle East and Africa
6.7.9.1. Rest of Middle East and Africa Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2021)
7. Company Profiles
7.1. GW Pharmaceuticals
7.1.1. Business Overview
7.1.2. Service Portfolio
7.1.3. Strategic Developments
7.1.4. Financial Overview
7.2. AbbVie Inc.
7.2.1. Business Overview
7.2.2. Service Portfolio
7.2.3. Strategic Developments
7.2.4. Financial Overview
7.3. Valeant Pharmaceuticals
7.3.1. Business Overview
7.3.2. Service Portfolio
7.3.3. Strategic Developments
7.3.4. Financial Overview
7.4. Insys Therapeutics, Inc.
7.4.1. Business Overview
7.4.2. Service Portfolio
7.4.3. Strategic Developments
7.4.4. Financial Overview
8. Cannabis Pharmaceuticals Market Forecast (2022-2027)
8.1. Global Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2022-2027)
8.2. Cannabis Pharmaceuticals Market Forecast by Regions (2022-2027)
8.2.1. North America Cannabis Pharmaceuticals Market Forecast (2022-2027)
8.2.1.1. United States Cannabis Pharmaceuticals Market Forecast (2022-2027)
8.2.1.2. Canada Cannabis Pharmaceuticals Market Forecast (2022-2027)
8.2.1.3. Mexico Cannabis Pharmaceuticals Market Forecast (2022-2027)
8.2.2. Europe Cannabis Pharmaceuticals Market Forecast (2022-2027)
8.2.2.1. Germany Cannabis Pharmaceuticals Market Forecast (2022-2027)
8.2.2.2. France Cannabis Pharmaceuticals Market Forecast (2022-2027)
8.2.2.3. UK Cannabis Pharmaceuticals Market Forecast (2022-2027)
8.2.2.4. Russia Cannabis Pharmaceuticals Market Forecast (2022-2027)
8.2.2.5. Italy Cannabis Pharmaceuticals Market Forecast (2022-2027)
8.2.2.6. Rest of Europe Cannabis Pharmaceuticals Market Forecast (2022-2027)
8.2.3. Asia-Pacific Cannabis Pharmaceuticals Market Forecast (2022-2027)
8.2.3.1. China Cannabis Pharmaceuticals Market Forecast (2022-2027)
8.2.3.2. Japan Cannabis Pharmaceuticals Market Forecast (2022-2027)
8.2.3.3. Korea Cannabis Pharmaceuticals Market Forecast (2022-2027)
8.2.3.4. India Cannabis Pharmaceuticals Market Forecast (2022-2027)
8.2.3.5. Southeast Asia Cannabis Pharmaceuticals Market Forecast (2022-2027)
8.2.3.6. Rest of Asia-Pacific Cannabis Pharmaceuticals Market Forecast (2022-2027)
8.2.4. South America Cannabis Pharmaceuticals Market Forecast (2022-2027)
8.2.4.1. Brazil Cannabis Pharmaceuticals Market Forecast (2022-2027)
8.2.4.2. Argentina Cannabis Pharmaceuticals Market Forecast (2022-2027)
8.2.4.3. Columbia Cannabis Pharmaceuticals Market Forecast (2022-2027)
8.2.4.4. Rest of South America Cannabis Pharmaceuticals Market Forecast (2022-2027)
8.2.5. Middle East and Africa Cannabis Pharmaceuticals Market Forecast (2022-2027)
8.2.5.1. Saudi Arabia Cannabis Pharmaceuticals Market Forecast (2022-2027)
8.2.5.2. United Arab Emirates Cannabis Pharmaceuticals Market Forecast (2022-2027)
8.2.5.3. Egypt Cannabis Pharmaceuticals Market Forecast (2022-2027)
8.2.5.4. Nigeria Cannabis Pharmaceuticals Market Forecast (2022-2027)
8.2.5.5. South Africa Cannabis Pharmaceuticals Market Forecast (2022-2027)
8.2.5.6. Turkey Cannabis Pharmaceuticals Market Forecast (2022-2027)
8.2.5.7. Rest of Middle East and Africa Cannabis Pharmaceuticals Market Forecast (2022-2027)
8.3. Cannabis Pharmaceuticals Market Forecast by Brand Type (2022-2027)
8.3.1. Cannabis Pharmaceuticals Forecast by Brand Type (2022-2027)
8.3.2. Cannabis Pharmaceuticals Market Share Forecast by Brand Type (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Cannabis Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Cannabis Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Cannabis Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Cannabis Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Cannabis Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Cannabis Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Cannabis Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Cannabis Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Cannabis Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Cannabis Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Cannabis Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Cannabis Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Cannabis Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Cannabis Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Cannabis Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Cannabis Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Cannabis Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Cannabis Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Cannabis Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Cannabis Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Cannabis Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Cannabis Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Cannabis Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Cannabis Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Cannabis Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Cannabis Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Cannabis Pharmaceuticals Revenue and Revenue Share by Brand Type (2017-2019)
Figure Global Sativex Revenue and Growth Rate (2017-2019)
Figure Global Epidiolex Revenue and Growth Rate (2017-2019)
Table Global Cannabis Pharmaceuticals Revenue by Regions (2017-2019)
Figure North America Cannabis Pharmaceuticals Growth Rate (2017-2019)
Figure North America Cannabis Pharmaceuticals Revenue and Growth Rate (2017-2019)
Figure North America Cannabis Pharmaceuticals by Countries (2017-2019)
Figure North America Cannabis Pharmaceuticals Revenue (Million USD) by Countries (2017-2019)
Figure United States Cannabis Pharmaceuticals Growth Rate (2017-2019)
Figure United States Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Cannabis Pharmaceuticals Growth Rate (2017-2019)
Figure Canada Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Cannabis Pharmaceuticals Growth Rate (2017-2019)
Figure Mexico Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Cannabis Pharmaceuticals Growth Rate (2017-2019)
Figure Europe Cannabis Pharmaceuticals Revenue and Growth Rate (2017-2019)
Figure Europe Cannabis Pharmaceuticals by Countries (2017-2019)
Figure Europe Cannabis Pharmaceuticals Revenue (Million USD) by Countries (2017-2019)
Figure Germany Cannabis Pharmaceuticals Growth Rate (2017-2019)
Figure Germany Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Cannabis Pharmaceuticals Growth Rate (2017-2019)
Figure France Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Cannabis Pharmaceuticals Growth Rate (2017-2019)
Figure UK Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Cannabis Pharmaceuticals Growth Rate (2017-2019)
Figure Russia Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Cannabis Pharmaceuticals Growth Rate (2017-2019)
Figure Italy Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Cannabis Pharmaceuticals Growth Rate (2017-2019)
Figure Rest of Europe Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Cannabis Pharmaceuticals Growth Rate (2017-2019)
Figure Asia-Pacific Cannabis Pharmaceuticals Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Cannabis Pharmaceuticals by Countries (2017-2019)
Figure Asia-Pacific Cannabis Pharmaceuticals Revenue (Million USD) by Countries (2017-2019)
Figure China Cannabis Pharmaceuticals Growth Rate (2017-2019)
Figure China Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Cannabis Pharmaceuticals Growth Rate (2017-2019)
Figure Japan Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Cannabis Pharmaceuticals Growth Rate (2017-2019)
Figure Korea Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Cannabis Pharmaceuticals Growth Rate (2017-2019)
Figure India Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Cannabis Pharmaceuticals Growth Rate (2017-2019)
Figure Southeast Asia Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Cannabis Pharmaceuticals Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Cannabis Pharmaceuticals Growth Rate (2017-2019)
Figure South America Cannabis Pharmaceuticals Revenue and Growth Rate (2017-2019)
Figure South America Cannabis Pharmaceuticals by Countries (2017-2019)
Figure South America Cannabis Pharmaceuticals Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Cannabis Pharmaceuticals Growth Rate (2017-2019)
Figure Brazil Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Cannabis Pharmaceuticals Growth Rate (2017-2019)
Figure Argentina Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Cannabis Pharmaceuticals Growth Rate (2017-2019)
Figure Columbia Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Cannabis Pharmaceuticals Growth Rate (2017-2019)
Figure Rest of South America Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Cannabis Pharmaceuticals Growth Rate (2017-2019)
Figure Middle East and Africa Cannabis Pharmaceuticals Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Cannabis Pharmaceuticals by Countries (2017-2019)
Figure Middle East and Africa Cannabis Pharmaceuticals Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Cannabis Pharmaceuticals Growth Rate (2017-2019)
Figure Saudi Arabia Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Cannabis Pharmaceuticals Growth Rate (2017-2019)
Figure United Arab Emirates Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Cannabis Pharmaceuticals Growth Rate (2017-2019)
Figure Egypt Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Cannabis Pharmaceuticals Growth Rate (2017-2019)
Figure Nigeria Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Cannabis Pharmaceuticals Growth Rate (2017-2019)
Figure South Africa Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Cannabis Pharmaceuticals Growth Rate (2017-2019)
Figure Turkey Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Cannabis Pharmaceuticals Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2019)
Table GW Pharmaceuticals Cannabis Pharmaceuticals Financial Overview
Table AbbVie Inc. Cannabis Pharmaceuticals Financial Overview
Table Valeant Pharmaceuticals Cannabis Pharmaceuticals Financial Overview
Table Insys Therapeutics, Inc. Cannabis Pharmaceuticals Financial Overview
Figure Global Cannabis Pharmaceuticals Revenue (Millions USD) and Growth Rate (2019-2027)
Table Cannabis Pharmaceuticals Market Forecast by Regions (2019-2027)
Figure North America Cannabis Pharmaceuticals Market Forecast (2019-2027)
Figure United States Cannabis Pharmaceuticals Market Forecast (2019-2027)
Figure Canada Cannabis Pharmaceuticals Market Forecast (2019-2027)
Figure Mexico Cannabis Pharmaceuticals Market Forecast (2019-2027)
Figure Europe Cannabis Pharmaceuticals Market Forecast (2019-2027)
Figure Germany Cannabis Pharmaceuticals Market Forecast (2019-2027)
Figure France Cannabis Pharmaceuticals Market Forecast (2019-2027)
Figure UK Cannabis Pharmaceuticals Market Forecast (2019-2027)
Figure Russia Cannabis Pharmaceuticals Market Forecast (2019-2027)
Figure Italy Cannabis Pharmaceuticals Market Forecast (2019-2027)
Figure Rest of Europe Cannabis Pharmaceuticals Market Forecast (2019-2027)
Figure Asia-Pacific Cannabis Pharmaceuticals Market Forecast (2019-2027)
Figure China Cannabis Pharmaceuticals Market Forecast (2019-2027)
Figure Japan Cannabis Pharmaceuticals Market Forecast (2019-2027)
Figure Korea Cannabis Pharmaceuticals Market Forecast (2019-2027)
Figure India Cannabis Pharmaceuticals Market Forecast (2019-2027)
Figure Southeast Asia Cannabis Pharmaceuticals Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Cannabis Pharmaceuticals Market Forecast (2019-2027)
Figure South America Cannabis Pharmaceuticals Market Forecast (2019-2027)
Figure Brazil Cannabis Pharmaceuticals Market Forecast (2019-2027)
Figure Argentina Cannabis Pharmaceuticals Market Forecast (2019-2027)
Figure Columbia Cannabis Pharmaceuticals Market Forecast (2019-2027)
Figure Rest of South America Cannabis Pharmaceuticals Market Forecast (2019-2027)
Figure Middle East and Africa Cannabis Pharmaceuticals Market Forecast (2019-2027)
Figure Saudi Arabia Cannabis Pharmaceuticals Market Forecast (2019-2027)
Figure United Arab Emirates Cannabis Pharmaceuticals Market Forecast (2019-2027)
Figure Egypt Cannabis Pharmaceuticals Market Forecast (2019-2027)
Figure Nigeria Cannabis Pharmaceuticals Market Forecast (2019-2027)
Figure South Africa Cannabis Pharmaceuticals Market Forecast (2019-2027)
Figure Turkey Cannabis Pharmaceuticals Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Cannabis Pharmaceuticals Market Forecast (2019-2027)
Figure Global Cannabis Pharmaceuticals Forecast by Brand Type (2019-2027)
Figure Global Cannabis Pharmaceuticals Market Share Forecast by Brand Type (2019-2027)
Figure Global Cannabis Pharmaceuticals Forecast by Brand Type (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|